CDC Report Highlights RSV Vaccine Safety Findings for Adults 60 and Older

Published: 05/31/2024

Sources:
  • Centers for Disease Control and Prevention
Relevant To:
  • Assisted Living,
  • Medical Office,
  • Critical Access Hospitals,
  • Hospitals,
  • Long Term Care,
  • Ambulatory Care,
  • Pharmacy,
  • Rural Health Clinics

The U.S. Centers for Disease Control and Prevention new Morbidity and Mortality Weekly Report (MMWR) highlights safety findings for two respiratory syncytial virus (RSV) vaccines licensed in May 2023 by the Food and Drug Administration (FDA) for adults 60 years and older. 

Accordign to the CDC, early findings from reports made to the Vaccine Adverse Event Reporting System (VAERS) and V-safe suggest that the safety of GSK and Pfizer RSV vaccines is consistent with vaccine safety data seen in c…

Sign Up for Free Trial